Tag: Medtronics
MiniMed analysis shows high rates of time in range
June 3, 2021HME News Staff
DUBLIN, Ireland – Diabetes patients using Medtronics’ MiniMed 780G system saw an average overall time in range of 76.2% and an overnight time in range of 83%, according to an analysis of 4,120 individuals with Type 1 diabetes. "It is extremely encouraging to see Medtronic advancing both clinical outcomes, as well as the user experience through their latest MiniMed 780G system,” said Prof. Chantal Mathieu, endocrinologist at University Hospitals Leuven-KULeuven, Belgium. “It...
Sponsored Stories
How Advanced Diabetes Supply is Driving Value-Based Health Outcomes
By Advanced Diabetes SupplySOS Achieves Remarkable 400% Growth in 2023, Bolsters Team with Director Appointment
By Strategic Office SupportCyber Siege: The Financial Vulnerability Healthcare Didn't See Coming
By Strategic Office SupportA new staffing model that delivers ready-to-work pros, boosting efficiency and lowering costs.
By Tactical Back Office